HANDAYANI, F., FITRIA, N., SARI, Y. O., & A., A. (2025). IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY. International Journal of Applied Pharmaceutics, 17(1), 82–88. https://doi.org/10.22159/ijap.2025.v17s1.12